Developmental Erythropoiesis

Fetal and Neonatal Physiology: Third Edition

Volumn 2-2, Issue , 2003, Pages 1397-1420

  Ohls, Robin K ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b University of New Mexico School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84911110470     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9654-6.50149-1     Document Type: Chapter

References (240)

1. Keleman E, et al. Atlas of Human Hemopoietic Development. Atlas of Human Hematopoietic Tissue 1979, 1-261. Springer-Verlag, New York.
2. Gilmore JR Normal hematopoiesis in intra-uterine and neonatal life. J Pathol Bacteriol 1941, 52:25.
3. Takashina T Haemopoiesis in the human yolk sac. J Anat 1987, 151:125.
4. Moore KL The Developing Human: Clinically Oriented Embryology 1988, WB Saunders Co, Philadelphia. 4th ed.
5. Wood WG Hemoglobin synthesis during fetal development. Br Med Bull 1976, 32:282.
6. Dgaldetti M Hematopoietic events in human embryonic spleens at early gestational ages. Biol Neonate 1979, 36:133.
7. Calhoun DA, et al. Assessment of the contribution of the spleen to granulocytopoiesis and erythropoiesis of the mid-gestation human fetus. Early Hum Dev 1996, 46:217.
8. Moore MAS, Metcalf D Ontogeny of the hematopoietic system: Yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol 1970, 18:279.
9. Yoder M, Hiatt K Engraftment of embryonic hematopoietic cells in conditioned newborn recipients. Blood 1997, 89:2176.
10. Ohls RK, et al. Neutrophil pool sizes and granulocyte colony-stimulating factor production in human mid-trimester fetuses. Pediatr Res 1995, 37:806.
11. Forestier F, et al. Developmental hematopoiesis in normal human fetal blood. Blood 1991, 77:2360.
12. Rosse C, et al. Bone marrow cell populations of normal infants: the predominance of lymphocytes. J Lab Clin Med 1977, 89:1225.
13. Carbonell F, et al. Cellular composition of human fetal bone marrow. Acta Anat 1982, 113:371.
14. Sieff CA, et al. Dependence of highly enriched human bone marrow progenitors on hematopoietic growth factors and their response to recombinant erythropoietin. J Clin Invest 1986, 77:74.
15. Lipton JM, et al. Response of three classes of human erythroid progenitors to the absence of erythropoietin in vitro as a measure of progenitor maturity. Exp Hematol 1981, 9:1035.
16. Hematopoietic Stem Cells 1985, 20-43. Marcel Dekker, New York. D.W. Golde, F. Takaku (Eds.).
17. Heath DS, et al. Separation of the erythropoietin-responsive progenitors BFU-E and CFU-E in mouse bone marrow by unit gravity sedimentation. Blood 1976, 47:777.
18. Spivak JL The mechanism of action of erythropoietin. Int J Cell Cloning 1986, 4:139.
19. Dessypris EN, et al. Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood 1988, 72:2060.
20. Jacobs K, et al. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985, 313:806.
21. Schibler KS, et al. Effect of recombinant stem cell factor on clonogenic maturation and cycle status of human fetal hematopoietic progenitors. Pediatr Res 1994, 35:303.
22. Umemura T, et al. The mechanism of expansion of late erythroid progenitors during erythroid regeneration: target cells and effects of erythropoietin and interleukin-3. Blood 1989, 73:1993.
23. Gardner JD, et al. Effects of interleukin-6 on fetal hematopoietic progenitors. Blood 1990, 75:2150.
24. Holbrook ST, et al. Effect of interleukin-9 on clonogenic maturation and cell-cycle status of fetal and adult hematopoietic progenitors. Blood 1991, 77:2129.
25. Kaushansky K, et al. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?. Stem Cells 1996, 14(Suppl 1):108.
26. Emerson SG, et al. Developmental regulation of erythropoiesis by hematopoietic growth factors: analysis on populations of BFU-E from bone marrow, peripheral blood, and fetal liver. Blood 1989, 74:49.
27. Valtieri M, et al. Erythropoietin alone induces erythroid burst formation by human embryonic but not adult BFU-E in unicellular serum-free culture. Blood 1989, 74:460.
28. Schibler KR, et al. Possible mechanisms accounting for the growth factor independence of hematopoietic progenitors from umbilical cord blood. Blood 1994, 84:3679.
29. Zanjani ED, et al. Erythropoietin does not cross the placenta into the fetus. Pathobiology 1993, 61:211.
30. Malek A, et al. Lack of transport of erythropoietin across the human placenta as studied by an in vitro perfusion system. Pflugers Arch 1994, 427:157.
31. 125I-erythropoietin in sheep. J Dev Physiol 1991, 15:139.
32. 125I-erythropoietin by the placenta. J Clin Invest 1988, 82:154.
33. Jacobsen LO, et al. The effect of transfusion-induced polycythemia in the mother of the fetus. Blood 1959, 14:694.
34. Matoth Y, Zaizov R Regulation of erythropoiesis in the fetal rat. Proceedings of the Tel Aviv University Conference on Erythropoiesis 1970, 24. Academic Press, New York. P. Tikva (Ed.).
35. Goldberg MA, et al. Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein. Science 1988, 242:524.
36. Peschle C, et al. Erythropoietin production by the liver in fetal-neonatal life. Life Sci 1975, 17:1325.
37. Imagawa S, et al. Regulatory elements of the erythropoietin gene. Blood 1991, 77:278.
38. Fried W The liver as a source of extrarenal erythropoietin production. Blood 1972, 40:671.
39. Erslev AJ, et al. Renal and extrarenal erythropoietin production in anemic rats. Br J Haematol 1980, 45:65.
40. Naughton VA, et al. Hepatic and renal erythropoietin production during various intervals of short-term hypoxia. J Med 1984, 15:45.
41. Beru N, et al. Expression of erythropoietin gene. Mol Cell Biol 1986, 25:71.
42. Arnaud S, Blanchet JP Mouse serum enables CFU-E to grow under physiologic concentration of erythropoietin in vitro. Exp Hematol 1986, 14:143.
43. DeWitte T, et al. Influence of peripheral blood admixture on the number of hematopoietic progenitor cells (CFU-GM and BFU-E) in human bone marrow aspirates. Acta Haematol 1985, 70:74.
44. Zanjani ED, Banisadre M Hormonal stimulation of erythropoietin production and erythropoiesis in anephric sheep fetuses. J Clin Invest 1979, 64:1181.
45. Udupa KB, et al. In vitro culture of proerythroblasts: Characterization of proliferative response to erythropoietin and steroids. Br J Haematol 1986, 62:705.
46. Zanjani ED, et al. Effects of thyroid hormone on erythropoiesis and the switch from fetal to adult hemoglobin synthesis in fetal sheep. Cellular and Molecular Regulation of Hemoglobin Switching 1979, 169-178. Grune & Stratton, New York. G. Stamatoyannopoulos, A.W. Nienhuis (Eds.).
47. 2 mediated effects on synthesis of fetal and adult hemoglobin in blood erythroid bursts. Prostaglandins 1985, 29:561.
48. Drake JR, Fitch CD Status of vitamin E as an erythropoietic factor. Am J Clin Nutr 1980, 33:2386.
49. Konwalinka G, et al. Effect of human plasma lipoproteins on the erythropoietic progenitor cells in serum-free cultures. Blut 1986, 52:191.
50. Zanjani ED, et al. Liver as primary site of erythropoietin formation in the fetus. J Lab Clin Med 1977, 89:640.
51. Widness JA, et al. Erythropoietin levels and erythropoiesis at birth in infants with Potter's syndrome. J Pediatr 1990, 117:155.
52. Lim GB, et al. Ontogeny of erythropoietin gene expression in the sheep fetus: Effect of dexamethasone at 60 days gestation. Blood 1994, 83:460.
53. Dame C, et al. Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood 1998, 92:3218.
54. Ohls RK Erythropoietin and hypoxia inducible factor-1 expression in the mid-trimester human fetus. Acta Pediatr 2002, 91:27.
55. Halvorsen S, Finne PH Erythropoietin production in the human fetus and newborn. Ann NY Acad Sci 1968, 149:576.
56. Meberg A Hemoglobin concentration and erythropoietin levels inappropriate in small for gestational age infants. Scand J Haematol 1980, 24:162.
57. Thomas RM, et al. Erythropoietin in cord blood hemoglobin and the regulation of fetal erythropoiesis. Br J Obstet Gynaecol 1983, 90:795.
58. Widness JA, et al. Increased immunoreactive erythropoietin in cord blood after labor. Am J Obstet Gynecol 1984, 148:194.
59. Stevenson DK, et al. Increased immunoreactive erythropoietin in cord blood and neonatal bilirubin production in normal term infants after labor. Obstet Gynecol 1986, 67:69.
60. Finne PH Erythropoietin levels in cord blood as an indicator of intrauterine hypoxia. Acta Paediatr Scand 1986, 55:478.
61. Widness JA, et al. Correlation of the interpretation of fetal heart rate records with cord plasma erythropoietin levels. Br J Obstet Gynaecol 1985, 92:326.
62. Erslev AJ, et al. Erythropoietin titers in anemic, nonuremic patients. J Lab Clin Med 1987, 109:429.
63. Oski FA The erythrocyte and its disorders. Hematology of Infancy and Childhood 1993, 18-43. WB Saunders Co, Philadelphia. F.A. Oski, D.G. Nathan (Eds.).
64. Usher R, et al. The blood volume of a newborn infant and placental transfusion. Acta Paediatr Scand 1963, 52:497.
65. Oettinger L, Mills WB Simultaneous capillary and venous hemoglobin determinations in newborn infants. J Pediatr 1949, 35:362.
66. Bratteby L Studies on the erythro-kinetics in infancy: red cell volume of newborn infants in relation to gestational age. Acta Paediatr Scand 1968, 57:132.
67. Walker J, Turnbull EPN Hemoglobin and red cells in the human fetus and the relation to oxygen content of the blood of the vessels of the umbilical cord. Lancet 1953, 2:312.
68. Burman D, Morris AF Cord hemoglobin and low birth weight infants. Arch Dis Child 1974, 49:382.
69. Marks J, et al. Blood formation in infancy. III. Cord blood. Arch Dis Child 1955, 30:117.
70. Guest GM, Brown EW Erythrocytes and hemoglobin of the blood in infancy and childhood. III. Factors in variability, statistical studies. Am J Dis Child 1957, 93:486.
71. Mollison PL, et al. Red cell and plasma volume in newborn infants. Arch Dis Child 1950, 25:242.
72. Humbert JR, et al. Polycythemia in small for gestational age infants. J Pediatr 1969, 75:812.
73. Moore LG, et al. Increased incidence of neonatal hyperbilirubinemia at 3100 m in Colorado. Am J Dis Child 1984, 138:158.
74. Brown MS Fetal and neonatal erythropoiesis. Developmental and Neonatal Hematology 1988, Raven Press, New York. J.A. Stockman, C. Pochedly (Eds.).
75. Stockman JA, et al. The anemia of prematurity: factors governing the erythropoietin response. N Engl J Med 1977, 296:647.
76. Stockman JA, Oski FA Red blood cell values in low birth weight infants during the first seven weeks of life. Am J Dis Child 1980, 134:945.
77. Grauel EL, et al. Separation and characterization of red blood cells from newborns and infants during the first trimenon of life using a dextran density gradient, mean corpuscular volume and mean cellular hemoglobin concentration. Acta Haematol 1982, 67:102.
78. Delivoria-Papadopoulos M, et al. Postnatal changes in oxygen transport of term, preterm and sick infants: the role of red cell 2,3 diphosphoglycerate in adult hemoglobin. Pediatr Res 1971, 5:235.
79. Hakanson DO, Oh W Hyperviscosity in the small for gestational age infant. Pediatr Res 1977, 11:472A.
80. 50, 2,3-diphosphoglycerate, total hemoglobin, hematocrit, and type F hemoglobin in fetal blood. Pediatrics 1983, 2:22.
81. Matoth Y, et al. Postnatal changes in some red cell parameters. Acta Paediatr Scand 1971, 60:317.
82. Oh W, Lind J Venous and capillary hematocrit in newborn infants and placental transfusion. Acta Paediatr Scand 1966, 55:38.
83. Scott JR, Warenski JC Tests to detect and quantitate fetal maternal bleeding. Clin Obstet Gynecol 1982, 25:277.
84. Bowman JM Maternal blood group immunization. Assessment and Care of the Fetus. Physiologic, Clinical and Medicolegal Principles 1989, 749-772. Appleton & Lange, Norwalk, CT. R.D. Eden, F.H. Boehm (Eds.).
85. Kleihauer E, et al. Demonstration of fetal hemoglobin in the erythrocytes of the blood of a newborn. Klin Wochenschr 1957, 35:637.
86. Weatherall DJ, et al. The developmental genetics of human hemoglobin. Experimental Approaches for the Study of Hemoglobin Switching 1985, 3-25. Alan R Liss, New York. G. Stamatoyannopoulos, A.W. Nienhuis (Eds.).
87. Leder A, et al. In situ hybridization reveals co-expression of embryonic and adult alpha-globin genes in the earliest murine erythrocyte progenitors. Development 1992, 116:1041.
88. Chui DH, et al. Human embryonic zeta-globin chains in fetal and newborn blood. Blood 1989, 74:1409.
89. Malala B, et al. A study of the switch of fetal hemoglobin and newborn erythrocytes fractionated by density gradient. Hemoglobin 1983, 7:567.
90. Safaya S, et al. Augmentation of gamma-globin gene promoter activity by carboxylic acids and components of the human beta-globin locus control region. Blood 1994, 84:3929.
91. Stamatoyannopoulos G, et al. Fetal hemoglobin induction by acetate, a product of butyrate catabolism. Blood 1994, 84:3198.
92. Wood WG, Weatherall DJ Developmental genetics of the human hemoglobins. Biochem J 1983, 215:1.
93. deBoer E, et al. The human beta-globin promoter: nuclear protein factors and erythroid specific induction of transcription. EMBO J 1988, 7:4203.
94. Vitale M, et al. Evidence for a globin promoter-specific silencer element located upstream of the human delta-globin gene. Biochem Biophys Res Commun 1994, 204:413.
95. Cao S-X, et al. Identification of a transcriptional silencer in the 5' flanking region of the human epsilon-globin gene. Proc Natl Acad Sci U S A 1989, 86:5306.
96. Huehns ER, et al. Developmental hemoglobin anomalies in a chromosomal triplication: D1 trisomy syndrome. Proc Natl Acad Sci U S A 1964, 51:89.
97. Papayannopoulou T, et al. Asynchronous synthesis of HbF and HbA during erythroblast maturation. II. Studies of G gamma, A gamma, and beta chain synthesis in individual erythroid clones from neonatal and adult BFU-E cultures. Blood 1981, 57:531.
98. Kleihauer E The hemoglobins. Physiology of the Perinatal Period 1970, Vol 1:255. Appleton-Century-Crofts, New York. U. Stave (Ed.).
99. Peschle C, et al. Hemoglobin switching in the human embryos: a synchrony of the zeta to alpha and epsilon to gamma-globin genes in primitive and definitive erythropoietic lineage. Nature 1985, 313:235.
100. Phillips HM, et al. Definitive estimate of the rate of hemoglobin switching: measurement of percent hemoglobin F in neonatal erythrocytes. Pediatr Res 1988, 23:595.
101. Schröeder WA, et al. Worldwide occurrence of nonallelic genes for the gamma-chain of human foetal haemoglobin in newborns. Nature 1972, 240:273.
102. Schröeder WA, et al. Postnatal changes in chemical heterogeneity of human fetal hemoglobin. Pediatr Res 1971, 5:473.
103. Schröeder WA, Huisman THJ Human gamma-chains: structural features. Cellular and Molecular Regulation of Hemoglobin Switching 1979, 29-45. Grune & Stratton, New York. G. Stamatoyannopoulos, A.W. Nienhuis (Eds.).
104. Szelengi JG, Holland SR Studies on the structure of human embryonic hemoglobin. Acta Biochim Biophys Acad Sci Hung 1969, 4:47.
105. Hecht F, et al. Predominance of hemoglobin Gower 1 in early human embryonic development. Science 1966, 152:91.
106. Huehns ER, et al. Human embryonic hemoglobins. Symp Quant Biol 1964, 29:327.
107. Heizman THJ, et al. Further studies of the postnatal change in chemical heterogeneity of human fetal hemoglobin in several abnormal conditions. Pediatr Res 1975, 9:1.
108. Bard H, et al. The reactivation of fetal hemoglobin synthesis during anemia of prematurity. Pediar Res 1994, 36:253.
109. Bard H, et al. Hypoxemia and increased fetal hemoglobin synthesis. J Pediatr 1994, 124:941.
110. Bromberg YM, et al. The effect of maternal anoxaemia on the foetal hemoglobin. J Obstet Gynaecol 1956, 63:875.
111. Bard H The effect of placental insufficiency on fetal hemoglobin and adult hemoglobin synthesis. Am J Obstet Gynecol 1974, 120:67.
112. Bard H, Prosmanne J Relative rates of fetal hemoglobin and adult hemoglobin synthesis in the cord blood of infants of insulin-dependent diabetic mothers. Pediatrics 1985, 75:1143.
113. Perrine SP, et al. Delay in fetal hemoglobin switch in infants of diabetic mothers. N Engl J Med 1985, 312:334.
114. Platt OS, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994, 330:1639.
115. Peschle C, Condorelli M Regulation of fetal and adult erythropoiesis. Congenital Disorders of Erythropoiesis 1976, Vol 37:25. Ciba Foundation, Amsterdam.
116. Travis SF, et al. Metabolic alterations in the human erythrocyte produced by increases in glucose concentration. The role of the polyol pathway. J Clin Invest 1971, 50:2104.
117. Moses SW, et al. Glucose and glycogen metabolism in erythrocytes from normal and glycogen storage III subjects. J Clin Invest 1968, 47:1343.
118. Murphy JR Erythrocyte metabolism. II. Glucose metabolism and pathways. J Lab Clin Med 1960, 55:286.
119. Oski FA Red cell metabolism in the preterm infant. II. The pentose phosphate pathway. Pediatrics 1967, 39:689.
120. Gerlach E, et al. Metabolism of 2,3 diphosphoglycerate in the red blood cells under various experimental conditions. Red Cell Metabolism and Function 1970, 155. Plenum Press, New York. G. Brewer (Ed.).
121. Oski FA, Naiman JL Red cell metabolism in the premature infant. I. Adenosine triphosphate levels, adenosine triphosphate stability, and glucose consumption. Pediatrics 1965, 36:104.
122. Ng WG, et al. Galactokinase activity in human erythrocytes of individuals at different ages. J Lab Clin Med 1965, 66:115.
123. Travis SF, et al. Red cell metabolic alterations and postnatal life in term infants: glycolytic enzymes and glucose-6-phosphate dehydrogenase. Pediatr Res 1980, 14:1349.
124. Conrad PM, et al. Enzymatic activities and glutathione content of erythrocytes in the newborn: comparison with red cells of older subjects and those with comparable reticulocytosis. Acta Haematol 1972, 48:193.
125. Gross RT, Schroeder EAR The relationship of triphosphopyridine nucleotide content to abnormalities in the erythrocytes of preterm infants. J Pediatr 1963, 63:823.
126. Whittam R Transport and Diffusion of Red Blood Cells 1964, 192. Edward Arnold, London.
127. Nakao M, et al. Adenosine triphosphate in the shape of erythrocytes. J Biochem 1961, 49:487.
128. Koj A Biosynthesis of glutathione in human blood. Acta Biochem Biol 1962, 9:11.
129. Oliveira MM, Vaughan M Incorporation of fatty acids into phospholipids of erythrocyte membranes. J Lipid Res 1964, 5:156.
130. Stave U, Cara J Adenosinophosphate in Blut Frühgeborener. Biol Neonate 1961, 3:160.
131. DeLuca C, et al. Simultaneous multiple-column chromatography: its application to the separation of the adenine nucleotides of human erythrocytes. Anal Biochem 1962, 4:39.
132. Huennekens FM, et al. Electron transport sequence of methemoglobin reductase. Ann NY Acad Sci 1958, 75:167.
133. Gross RT, Hurwitz RE The pentose phosphate pathway in human erythrocytes: relationship between the age of the subject and enzyme activity. Pediatrics 1958, 22:453.
134. Schröter W, Tillman W Heinz body susceptibility of red cells and exchange transfusion. Acta Haematol 1973, 49:74.
135. Tillman W, et al. The formation of Heinz bodies in ghosts of human erythrocytes of adults and newborn infants. Clin Wochenschr 1973, 51:201.
136. Stockman JA, Clark DA Diminished antioxidant activity of newborn infants. Pediatr Res 1981, 15:684.
137. Carrell RW, Winterbourn CC Activated oxygen and hemolysis. Br J Haematol 1975, 30:259.
138. Stockman JA Newborn red cells, the nature of oxidant injury. Pediatr Res 1977, 11:41.
139. Benesch R, et al. Reciprocal binding of oxygen and diphosphoglycerate by human hemoglobin. Proc Natl Acad Sci U S A 1968, 59:526.
140. Childs RA, et al. Blood group I activity associated with band 3, the major intrinsic membrane protein of human erythrocytes. Biochem J 1978, 173:333.
141. Alter B Fetal erythropoiesis in bone marrow failure syndromes. Cellular and Molecular Regulation of Hemoglobin Switching 1979, 87-105. Grune & Stratton, New York. G. Stamatoyannopoulos, A.W. Nienhuis (Eds.).
142. Wranne L Studies on erythrokinetics in infancy. Acta Paediatr Scand 1967, 56:381.
143. Mollison PL The survival of transfused erythrocytes in hemolytic disease of the newborn. Arch Dis Child 1943, 18:161.
144. Brace RA, et al. Red blood cell life span in the ovine fetus. Am J Physiol 2000, 279:R1196.
145. Komazawa M, Oski FA Biochemical characteristics of "young" and "old" erythrocytes of the newborn infant. J Pediatr 1975, 87:102.
146. Schmidt-Sommerfield E, Penn D Carnitine and total parenteral nutrition of the neonate. Biol Neonate 1990, 58:81.
147. Bracci R, et al. Changes in erythrocyte properties during the first hours of life: electron spin resonance of reacting sulfhydryl groups. Pediatr Res 1988, 24:391.
148. Bohler T, et al. Mechanical fragility of erythrocyte membrane in neonates and adults. Pediatr Res 1992, 32:92.
149. Zipursky A, et al. The erythrocyte differential count in newborn infants. Am J Pediatr Hematol Oncol 1983, 5:45.
150. Holyrode CP, et al. The "pocked" erythrocyte. N Engl J Med 1969, 281:516.
151. Linderkamp O, et al. Blood viscosity and optimal hematocrit in preterm and full-term neonates in 50- to 500μm tubes. Pediatr Res 1992, 32:97.
152. Cook GMW, et al. Sialic acids and the electrokinetic charge of the human erythrocyte. Nature 1961, 191:45.
153. Eylar EH, et al. The contribution of sialic acid to the surface charge of the erythrocyte. J Biol Chem 1962, 237:1992.
154. Kosztolany G, Jobst K Electrokinetic analysis of the fetal erythrocyte membrane after trypsin digestion. Pediatr Res 1980, 14:138.
155. Calatroni A, et al. Erythrocyte membrane sialic acid in newborn infants. Acta Haematol 1984, 71:198.
156. Adler SM, Denton RL The erythrocyte sedimentation rate in the newborn. J Pediatr 1975, 86:942.
157. Linderkamp O, Meiselman HJ Geometric and membrane mechanical properties of density separated human red cells. Blood 1982, 59:1121.
158. Goldblume A, Gotlieb R Icterus neonatorum. Am J Dis Child 1929, 38:57.
159. Wheh TR, et al. Studies on newborns. Am J Med Sci 1939, 198:646.
160. Schröter W, Kahsnitz E Diagnosis of hereditary spherocytosis in newborn infants. J Pediatr 1983, 103:460.
161. Hendricks S, et al. Insulin binding to erythrocytes of normal infants, children and adults: variation with age and sex. J Clin Endocrinol Metab 1981, 52:969.
162. Herzberg VL, et al. Insulin receptor binding to cord blood erythrocytes of varying gestational age and composition with adult values. Pediatr Res 1980, 14:4.
163. Kearin M, et al. Digoxin receptors in neonates: an explanation of less sensitivity to digoxin in adults. Clin Pharmacol Ther 1980, 28:346.
164. Toivanen B, Hirvonen T Iso- and heteroagglutinins in human fetal and neonatal sera. Scand J Haematol 1969, 6:42.
165. Marsh WL, Allen FH Erythrocyte blood groups in humans. Hematology of Infancy and Childhood 1987, 1497-1521. WB Saunders Co, Philadelphia. 3rd ed. D.G. Nathan, F.A. Oski (Eds.).
166. Thomaidis T, et al. Natural isohemagglutinin production by the fetus. J Pediatr 1969, 74:39.
167. Gartner OT, et al. Anti-A and anti-B antibodies in children. JAMA 1967, 201:206.
168. Stockman JA Anemia of prematurity. Clin Perinatol 1977, 4:239.
169. Stockman JA Anemia of prematurity: current concepts in the issue of when to transfuse. Pediatr Clin North Am 1986, 33:111.
170. Soubasi V, et al. Use of erythropoietin and its effects on blood lactate and 2, 3-diphosphoglycerate in premature neonates. Biol Neonate 2000, 78:281.
171. Oski FA, Stockman JA Anaemia in early infancy. Br J Haematol 1974, 27:195.
172. 2. Am Rev Respir Dis 1977, 115:173.
173. Wimberley PD Fetal hemoglobin, 2,3-diphosphoglycerate and oxygen transport in the newborn premature infant. Scand J Clin Lab Invest Suppl 1982, 161:1.
174. 50: effects on oxygen delivery when arterial hypoxemia is due to shunting. Chest 1980, 77:142.
175. Novy MJ, et al. Changes in umbilical-cord blood oxygen affinity after intrauterine transfusions for erythroblastosis. N Engl J Med 1971, 285:589.
176. Williams ML, et al. Role of dietary iron and fat in vitamin E deficiency anemia of infancy. N Engl J Med 1975, 292:887.
177. Stockman JA, et al. Anemia of prematurity: determinants of the erythropoietin response. J Pediatr 1984, 105:786.
178. Ohls RK Evaluation and treatment of anemia in the neonate. Hematologic Problems in the Neonate 2000, WB Saunders Company, Philadelphia. R.D. Christensen (Ed.).
179. Brown MS, et al. Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity. J Pediatr 1984, 105:793.
180. Ross MP, et al. A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age. J Perinatol 1989, 9:246.
181. Bifano EM, et al. Relationship between determinants of oxygen delivery and respiratory abnormalities in preterm infants with anemia. J Pediatr 1992, 120:292.
182. Keyes WG, et al. Assessing the need for transfusion of premature infants and the role of hematocrit, clinical signs, and erythropoietin level. Pediatrics 1989, 84:412.
183. Izraeli S, et al. Lactic acid as a predictor for erythrocyte transfusion in healthy preterm infants with the anemia of prematurity. J Pediatr 1993, 122:629.
184. Schulman I The anemia of prematurity. J Pediatr 1959, 54:663.
185. Pearson HA Life-span of the fetal red blood cell. J Pediatr 1967, 70:166.
186. Bratteby LE Studies on erythrokinetics in infants. IX. Prediction of red cell volume from venous haematocrit in early infancy. Acta Pediatr Scand 1968, 7:125.
187. Shannon KM, et al. Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med 1987, 31:728.
188. Rhondeau SM, et al. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity.". J Pediatr 1988, 12:935.
189. Ohls RK, et al. Erythroid "burst promoting activity" in the serum of patients with the anemia of prematurity. J Pediatr 1990, 116:786.
190. Ohls RK, et al. Serum erythropoietin concentrations fail to increase following significant phlebotomy losses in ill, preterm infants. J Perinatol 1997, 17:465.
191. Ohls RK, et al. Erythropoietin production by preterm macrophages: implications regarding the anemia of prematurity. Pediatr Res 1994, 35:169.
192. Ohls RK The use of erythropoietin in neonates. Clin Perinatol 2000, 3:681.
193. Ohls RK Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity. Pediatr Drugs 2002, 4:111.
194. Maier RF, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very low birth weight infants. N Engl J Med 1994, 330:1173.
195. Meyer MP, et al. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics 1994, 93:918.
196. Shannon KM, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995, 95:1.
197. Ohls RK, et al. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo controlled trial. J Pediatr 1995, 126:421.
198. Ohls RK, et al. The effect of erythropoietin on the transfusion requirements of preterm infants ≤750 grams: a randomized, double-blind, placebo-controlled study. J Pediatr 1997, 131:66.
199. Maier RF, et al. High- versus low-dose erythropoietin in extremely low birth weight infants. J Pediatr 1998, 132:866.
200. Donato H, et al. Effect of early versus late recombinant human erythropoietin on transfusion requirements in premature infants: results of randomized, placebo-controlled, multicenter trial. Pediatrics 2000, 105:1066.
201. Ohls RK, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birthweight: a multi-center, randomized controlled trial. Pediatrics 2001, 108:934.
202. Maier RF, et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 grams. J Pediatr 2002, 140:7.
203. Bifano EM, et al. Impact of transfusion guidelines on transfusion practices in premature infants. Pediatrics 1994, 35:216A.
204. George JW, et al. Age-related differences in erythropoietic response to recombinant human erythropoietin: comparison in adult and infant Rhesus monkeys. Pediatr Res 1990, 28:567.
205. Widness JA, et al. Developmental changes in erythropoietin (Ep) pharmacokinetics in fetal and neonatal sheep. Pediatr Res 1990, 28:284.
206. Eschbach JW, et al. Correction of the anemia of end stage renal disease with recombinant human erythropoietin. N Engl J Med 1987, 310:73.
207. Brown MS, et al. Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration. J Pediatr 1993, 122:655.
208. Ohls RK, et al. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in parenteral nutrition solution. J Pediatr 1996, 128:518.
209. Brown KE, Keith JF Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial. Pediatrics 1999, 104:210.
210. Cogar AA, et al. Endothelin concentrations in preterm infants treated with human recombinant erythropoietin. Bio Neonate 2000, 77:105.
211. Halperin DS, et al. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr 1990, 116:779.
212. Ohls RK, Christensen RD Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr 1991, 119:781.
213. Beck D, et al. Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity. Eur J Pediatr 1991, 150:767.
214. Christensen RD, et al. Administration of erythropoietin to newborn rats results in diminished neutrophil production. Blood 1991, 78:1241.
215. Christensen RD, Rothstein G Erythropoietin affects the maturation pattern of fetal G-CSF-responsive progenitors. Am J Hematol 1992, 39:108.
216. Katoh K, et al. Direct evidence for erythropoietin-induced release of endothelin from peripheral vascular tissue. Life Sci 1994, 54:253.
217. Emmerson AJB, et al. Double blind trial of recombinant erythropoietin in preterm infants. Arch Dis Child 1993, 68:291.
218. Ehrenkranz R, et al. Neurodevelopmental outcome and growth at 18-22 months in extremely low birth weight infants treated with early erythropoietin and iron. Pediatr Res 2002, 51:291A.
219. Casadevall N, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002, 346:469.
220. Egrie JC Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer 2001, 84(Suppl 1):3.
221. Carnielli V, et al. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 1992, 121:98.
222. Friel JK, et al. Intravenous iron administration to very-low-birth-weight newborns receiving total and partial parenteral nutrition. JPEN J Parenter Enteral Nutr 1995, 19:114.
223. Meyer MP, et al. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. J Pediatr 1996, 129:258.
224. Pollak A, et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics 2001, 107:78.
225. Pathak A et al: Role of vitamin E in the treatment of anemia of prematurity. Arch Dis Child in press, 2003.
226. Millard DD, et al. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. J Pediatr 1990, 117:447.
227. Koenig JM, et al. Late hyporegenerative anemia in Rh hemolytic disease. J Pediatr 1989, 115:315.
228. Ohls RK, et al. Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease. Pediatrics 1992, 90:678.
229. Scaradavou A, et al. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia. J Pediatr 1993, 123:279.
230. Alverson DC, et al. Effect of booster blood transfusions on oxygen utilization in infants with bronchopulmonary dysplasia. J Pediatr 1988, 113:722.
231. Christensen RD, et al. Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia. J Pediatr 1992, 120:593.
232. Ohls RK, et al. A randomized, placebo-controlled trial of recombinant erythropoietin as treatment for the anemia of bronchopulmonary dysplasia. J Pediatr 1993, 123:996.
233. Shaddy RE, et al. Epoetin alpha therapy in infants awaiting heart transplantation. Arch Pediatr Adolesc Med 1995, 149:322.
234. Alexi-Meskishvili V, et al. Correction of cor triatriatum sinistrum in a Jehovah's Witness infant. Eur J Cardiothorac Surg 2000, 18:724.
235. Fearon JA, Weinthal J The use of recombinant erythropoietin in the reduction of blood transfusion rates in craniosynostosis repair in infants and children. Plast Reconstr Surg 2002, 109:2190.
236. Kling PJ, et al. Pharmacokinetics and pharmacodynamics of erythropoietin therapy in an infant with renal failure. J Pediatr 1992, 121:822.
237. Lakatos L, et al. "Bloodless" treatment of a Jehovah's Witness infant with ABO hemolytic disease. J Perinatol 1999, 19:530.
238. Dhodapkar KM, Blei F Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin. J Pediatr Hematol Oncol 2001, 1:69.
239. Tchernia G, et al. Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis. Hematol J 2000, 1:146.
240. DePalma L, Luban NLC Blood component therapy in the perinatal period: guidelines and recommendations. Semin Perinatol 1990, 14:403.